Taken together, these results suggest that Se-SDF could inhibit the pathogenesis of colitis in mice by promoting the release of anti-inflammatory cytokines (IL-10 in male and female mice) and suppressing pro-inflammatory cytokines (TNF-α and IL-6 in female mice, TNF-α in male mice). The gene discussed is IL6; the disease is colitis.